HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The homeopathic preparation Neurexan vs. valerian for the treatment of insomnia: an observational study.

Abstract
Insomnia is prevalent and complementary therapies are common, but data are lacking on the effectiveness and tolerability of preparations beyond valerian. Here we report on an open-label, prospective cohort study in 89 German centers offering both conventional and complementary therapies. Subjects received the homeopathic preparation Neurexan or valerian for 28 days. Doses were at physicians' judgments. Sleep duration and latency were evaluated based on patients' sleep diaries over 14 days; sleep quality was evaluated at 28 +/- 1 days. A total of 409 subjects were enrolled. The groups were balanced at baseline for age, sex, weight, and sleep disturbances. At day 14, both groups reported improved sleep latency and duration; latency was reduced from baseline by 37.3 +/- 36.3 min with Neurexan and by 38.2 +/- 38.5 min with valerian. The duration of sleep increased by 2.2 (+/-1.6) h in the Neurexan group and by 2.0 (+/-1.5) h in the valerian group. Differences between the groups in improvement on sleep duration were significantly in favor of Neurexan therapy at days 8, 12, and 14. At day 28, quality of sleep was improved in both groups with no significant differences between the treatments. Significantly more patients reported lack of daytime fatigue with Neurexan than with valerian therapies (49% vs. 32%; p < 0.05 for the comparison). For patients favorable towards a CAM-based therapy, Neurexan might be an effective and well-tolerated alternative to conventional valerian-based therapies for the treatment of mild to moderate insomnia.
AuthorsRainer Waldschütz, Peter Klein
JournalTheScientificWorldJournal (ScientificWorldJournal) Vol. 8 Pg. 411-20 (Apr 20 2008) ISSN: 1537-744X [Electronic] United States
PMID18454251 (Publication Type: Controlled Clinical Trial, Journal Article)
Chemical References
  • Materia Medica
  • Plant Extracts
  • neurexan
Topics
  • Adult
  • Aged
  • Female
  • Germany
  • Humans
  • Male
  • Materia Medica (therapeutic use)
  • Middle Aged
  • Phytotherapy (methods)
  • Plant Extracts (therapeutic use)
  • Sleep Initiation and Maintenance Disorders (diagnosis, drug therapy)
  • Treatment Outcome
  • Valerian (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: